<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05015764</url>
  </required_header>
  <id_info>
    <org_study_id>RCV-0005</org_study_id>
    <nct_id>NCT05015764</nct_id>
  </id_info>
  <brief_title>Reprieve Cardiovascular System for the Treatment of Subjects With Acute Decompensated Heart Failure Mechanistic Study</brief_title>
  <official_title>Reprieve Cardiovascular System for the Treatment of Subjects With Acute Decompensated Heart Failure Mechanistic Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Reprieve Cardiovascular, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Reprieve Cardiovascular, Inc</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Reprieve Cardiovascular System for the Treatment of Subjects with Acute Decompensated Heart&#xD;
      Failure Mechanistic Study&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 12, 2021</start_date>
  <completion_date type="Anticipated">February 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fractional Excretion of Sodium measured during therapy</measure>
    <time_frame>End of treatment, an average of 24 hours</time_frame>
    <description>Average fractional excretion of sodium across all patients measured during therapy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Device and Procedure related AEs and SAEs</measure>
    <time_frame>Through study completion, an average of 90 days</time_frame>
    <description>Rate of device and procedure related AEs and SAEs</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Reprieve Cardiovascular System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fluid Management</intervention_name>
    <description>Removal of excess extracellular fluid using diuretics</description>
    <arm_group_label>Standard of Care</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Reprieve Cardiovascular System</intervention_name>
    <description>System with Fluid Management Module</description>
    <arm_group_label>Reprieve Cardiovascular System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Hospitalized with a diagnosis of heart failure&#xD;
&#xD;
          2. Patients â‰¥ 18 years of age able to provide informed consent and comply with study&#xD;
             procedures.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Inability to place Foley catheter or IV catheter&#xD;
&#xD;
          2. Hemodynamic instability&#xD;
&#xD;
          3. Dyspnea due primarily to non-cardiac causes&#xD;
&#xD;
          4. Acute infection with evidence of systemic involvement&#xD;
&#xD;
          5. Inability to follow instructions or comply with follow-up procedures.&#xD;
&#xD;
          6. Other concomitant disease or condition that investigator deems unsuitable for the&#xD;
             study&#xD;
&#xD;
          7. Enrollment in another interventional trial during the index hospitalization&#xD;
&#xD;
          8. Life expectancy less than 3 months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Arslan Malik</last_name>
    <phone>7072371616</phone>
    <email>amalik@reprievecardio.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Israeli-Georgian Medical Research Clinic Helsicore</name>
      <address>
        <city>Tbilisi</city>
        <country>Georgia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mamuka Kobalava, M.D.</last_name>
      <phone>+995 032 243 33 43</phone>
      <email>info@helsicore.ge</email>
    </contact>
  </location>
  <location_countries>
    <country>Georgia</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 12, 2021</study_first_submitted>
  <study_first_submitted_qc>August 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2021</study_first_posted>
  <last_update_submitted>August 16, 2021</last_update_submitted>
  <last_update_submitted_qc>August 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

